ro 20683 has been researched along with dibucaine in 4 studies
Studies (ro 20683) | Trials (ro 20683) | Recent Studies (post-2010) (ro 20683) | Studies (dibucaine) | Trials (dibucaine) | Recent Studies (post-2010) (dibucaine) |
---|---|---|---|---|---|
8 | 0 | 0 | 1,073 | 34 | 60 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Britten, JJ; Whittaker, M | 1 |
Jensen, FS; Skovgaard, LT; Viby-Mogensen, J | 1 |
Evans, RT; Kovarik, Z; Simeon-Rudolf, V; Skrinjarić-Spoljar, M | 1 |
Kovarik, Z; Simeon-Rudolf, V | 1 |
4 other study(ies) available for ro 20683 and dibucaine
Article | Year |
---|---|
Recognition of the Ek1Ek1 homozygote for plasma cholinesterase.
Topics: Adult; Aged; Cholinesterases; Dibucaine; Female; Genotype; Homozygote; Humans; Male; Middle Aged; Pedigree; Quaternary Ammonium Compounds; Sodium Fluoride | 1990 |
Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Butyrylcholinesterase; Child; Cholinesterase Inhibitors; Denmark; Dibucaine; DNA; Female; Genes; Genetic Variation; Genotype; Heterozygote; Humans; Male; Middle Aged; Molecular Biology; Quaternary Ammonium Compounds; Sex Factors; Sodium Fluoride; Succinylcholine; Urea | 1995 |
An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
Topics: Apnea; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Dibucaine; Genetic Carrier Screening; Humans; Kinetics; Neuromuscular Depolarizing Agents; Phenotype; Quaternary Ammonium Compounds; Sodium Fluoride; Succinylcholine; Thiocholine | 1999 |
An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants.
Topics: Butyrylcholinesterase; Cholinesterase Inhibitors; Dibucaine; Humans; Phenotype; Quaternary Ammonium Compounds; Sodium Fluoride | 2003 |